{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.103G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "103"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "35"
          },
          "Description in input context": "c.103G>A (p.G35R)"
        },
        {
          "HGVS": "NM_000345.3:c.113G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "113"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "38"
          },
          "Description in input context": "c.113G>A (p.G38R)"
        },
        {
          "HGVS": "NM_000345.3:c.125G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "125"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "42"
          },
          "Description in input context": "c.125G>A (p.G42R)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005303"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "The experiment was conducted using SH-SY5Y cells expressing wild-type or mutant SNCA."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.103G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased α-synuclein aggregation and reduced protein turnover for the p.G35R variant."
        },
        {
          "Variant": "NM_000345.3:c.113G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced fibrillization and neurotoxicity for the p.G38R variant compared to wild-type."
        },
        {
          "Variant": "NM_000345.3:c.125G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased oligomerization and mitochondrial dysfunction for the p.G42R variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA-expressing cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis of protein aggregation levels."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein aggregation levels ≤ 20% compared to wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein aggregation levels ≥ 50% compared to wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic mice",
        "Description": "Immunofluorescence was performed on brain tissue from transgenic mice expressing mutant SNCA variants."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.103G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Accumulation of α-synuclein in Lewy body-like inclusions in the substantia nigra."
        },
        {
          "Variant": "NM_000345.3:c.113G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased neuronal loss in the striatum and enhanced α-synuclein phosphorylation."
        },
        {
          "Variant": "NM_000345.3:c.125G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Widespread neuronal degeneration and α-synuclein aggregation in the cortex."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five transgenic mice per group were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each brain section was imaged in quadruplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Brain tissue from wild-type mice was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative控制": "Yes",
        "Description": "Brain tissue from non-transgenic mice was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to compare fluorescence intensity between wild-type and mutant groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein fluorescence intensity ≤ 1.5× wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein fluorescence intensity ≥ 3× wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Protein degradation assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells",
        "Description": "Protein degradation rates were measured in HEK293 cells expressing mutant or wild-type SNCA."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.103G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Reduced proteasomal degradation of p.G35R mutant α-synuclein compared to wild-type."
        },
        {
          "Variant": "NM_000345.3:c.113G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Impaired autophagy-mediated clearance of p.G38R mutant α-synuclein."
        },
        {
          "Variant": "NM_000345.3:c.125G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result意图": "Increased ubiquitination and slower degradation kinetics for p.G42R mutant α-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA-expressing cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Kruskal-Wallis test was used to compare degradation rates between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein degradation rate ≥ 70% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein degradation rate ≤ 30% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}